Search

AstraZeneca's MedImmune expands biologics unit

AstraZeneca subsidiary MedImmune Inc opened a new biologics research and development centre in Cambridge, UK, a major expansion to its base at the former Cambridge Antibody Technology facility.

Why can’t Johnny compute?

With an estimated 40 per cent of the EU population lacking computer skills, it’s no wonder that the European Commission is launching a series of initiatives to promote digital literacy.

More money than sense

Cash-rich pharma is dropping any pretence they are buying cash-strapped biotech for access to innovative technology. What it wants is products. Let’s hope it doesn’t suffocate the feedstock of innovation in the process.